- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2891
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Role of bioactive fatty acids in nonalcoholic fatty liver disease ; volume:15 ; number:1 ; day:2 ; month:8 ; year:2016 ; pages:1-10 ; date:12.2015
Nutrition journal ; 15, Heft 1 (2.8.2016), 1-10, 12.2015
- Urheber
-
Juárez-Hernández, Eva
- Beteiligte Personen und Organisationen
-
Chavez-Tapia, Norberto C.
Uribe, Misael
Barbero-Becerra, Varenka J.
SpringerLink (Online service)
- DOI
-
10.1186/s12937-016-0191-8
- URN
-
urn:nbn:de:1111-2016080314629
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Juárez-Hernández, Eva
- Chavez-Tapia, Norberto C.
- Uribe, Misael
- Barbero-Becerra, Varenka J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease
Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice
Industrial Trans Fatty Acids Stimulate SREBP2‐Mediated Cholesterogenesis and Promote Non‐Alcoholic Fatty Liver Disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota
Nonalcoholic fatty liver disease and cardiovascular disease risk
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease
Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice
Industrial Trans Fatty Acids Stimulate SREBP2‐Mediated Cholesterogenesis and Promote Non‐Alcoholic Fatty Liver Disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota
Nonalcoholic fatty liver disease and cardiovascular disease risk
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease
Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice
Industrial Trans Fatty Acids Stimulate SREBP2‐Mediated Cholesterogenesis and Promote Non‐Alcoholic Fatty Liver Disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota